SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIGHINOLFI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.598
AS - Asia 1.898
EU - Europa 1.277
SA - Sud America 287
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 56
OC - Oceania 1
Totale 7.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.479
SG - Singapore 722
PL - Polonia 576
CN - Cina 387
VN - Vietnam 246
BR - Brasile 213
IT - Italia 176
HK - Hong Kong 157
DE - Germania 109
BD - Bangladesh 96
FI - Finlandia 89
GB - Regno Unito 86
ID - Indonesia 79
JP - Giappone 70
CA - Canada 60
FR - Francia 56
RU - Federazione Russa 47
IN - India 42
SE - Svezia 39
MX - Messico 35
AR - Argentina 26
NL - Olanda 22
ZA - Sudafrica 19
AT - Austria 18
ES - Italia 17
UA - Ucraina 16
TR - Turchia 14
IQ - Iraq 13
CO - Colombia 12
KE - Kenya 12
PH - Filippine 10
TH - Thailandia 10
VE - Venezuela 10
MA - Marocco 8
EC - Ecuador 7
JM - Giamaica 7
MY - Malesia 7
PE - Perù 7
PK - Pakistan 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CR - Costa Rica 6
IE - Irlanda 6
EG - Egitto 5
CH - Svizzera 4
LT - Lituania 4
PS - Palestinian Territory 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
AM - Armenia 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
JO - Giordania 2
LB - Libano 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
MR - Mauritania 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
RW - Ruanda 1
TG - Togo 1
TW - Taiwan 1
Totale 7.121
Salva come PNG Salva come JPEG
Città #
Warsaw 574
Ashburn 563
Singapore 408
San Jose 345
Fairfield 331
Santa Clara 236
Beijing 208
Hong Kong 154
Woodbridge 145
Council Bluffs 141
Seattle 134
Houston 122
Wilmington 113
Cambridge 101
Chandler 87
Dallas 73
Jakarta 71
Tokyo 70
Ho Chi Minh City 67
Los Angeles 66
Helsinki 63
New York 60
Hanoi 54
Dong Ket 52
Lauterbourg 49
Princeton 46
Ann Arbor 36
San Diego 36
Munich 31
London 27
São Paulo 25
Turku 24
Ferrara 23
Washington 23
Nuremberg 22
Bremen 20
Montreal 20
Mexico City 19
Orem 19
Chicago 18
Buffalo 17
Shanghai 17
Milan 16
Bologna 15
Santa Maria Di Sala 14
Brooklyn 13
Frankfurt am Main 13
Stockholm 12
Toronto 12
Boston 11
Da Nang 11
Johannesburg 11
Portsmouth 11
Atlanta 10
Boardman 10
San Francisco 10
Vienna 10
Chennai 9
Falls Church 9
Nairobi 9
Phoenix 9
Redwood City 9
Rome 9
The Dalles 9
Dhaka 8
Brasília 7
Denver 7
Haiphong 7
Moscow 7
Padova 7
Philadelphia 7
Shenzhen 7
Belo Horizonte 6
Cape Town 6
Charlotte 6
Miami 6
Mumbai 6
San José 6
The Bronx 6
Umeå 6
Utrecht 6
Can Tho 5
Des Moines 5
Guangzhou 5
Jacksonville 5
Poplar 5
Porto Alegre 5
Rio de Janeiro 5
Tianjin 5
Turin 5
Verona 5
Addison 4
Athens 4
Augusta 4
Birmingham 4
Blumenau 4
Calgary 4
Chiswick 4
Dublin 4
Florence 4
Totale 5.149
Salva come PNG Salva come JPEG
Nome #
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 261
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation 257
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 215
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 212
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 210
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy 208
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort 201
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 200
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 185
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 179
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 173
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 171
Disease progression in HIV Late Presenters: The role of HIV clinical indicator diseases prior to HIV diagnosis 170
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 169
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 168
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 165
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients 165
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 165
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 159
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 155
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 155
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort * 154
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 152
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 146
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 141
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 139
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 138
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing 138
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 137
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 135
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 134
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 133
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 132
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 129
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 129
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 127
ANTIRETROVIRAL THERAPY RESTORES NAÏVE T CELL FREQUENCIES OC 8 AND FUNCTIONALITY IN PLWH 124
COVID-19 in eastern Emilia: an unusual epidemiology in Northern Italy 123
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort 122
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 121
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study 120
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 120
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 115
IMMUNOSENESCENCE FEATURES ARE PARTIALLY RESTORED BY ANTIRETROVIRAL THERAPY 99
Switching from TDF to TAF or dual therapy (DT)-based regimens in HIV-infected individuals with viral load <= 50 copies/ml: does eGFR matter? 99
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 98
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 91
null 46
Totale 7.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022280 0 0 2 5 15 44 21 27 16 39 12 99
2022/2023252 47 10 9 11 44 25 10 36 34 2 16 8
2023/2024334 14 27 29 14 46 91 11 7 5 3 2 85
2024/20251.130 25 11 115 25 138 140 32 36 175 157 148 128
2025/20263.044 290 106 246 258 419 185 423 134 287 318 238 140
2026/2027324 63 169 92 0 0 0 0 0 0 0 0 0
Totale 7.285